To see the results of the EVRS Satisfaction Questionnaire click here
If you did not fill up the satifaction Questionnaire while in Istanbul.
Download it and fax it back to us to : +33 2 51 83 32 61
 
Sunday, September 12th
 
09:00 Opening of the registration at the Swissôtel  
13:00-19:00 Live Surgery (12 diabetic patients operated by 12 different surgeons)  
07:30 Welcome Reception in the Swissôtel Park  
 
Monday, September 13th
   
PATHOGENESIS AND RESEARCH
08:00 Opening
08:10 Update on diabetes. Jean-François Gauthier
08:25 Current epidemiology of DR. Claudia Lanzrath
08:33 Epidemiology of diabetic retinopathy in Egypt: A hospital-based study. Tamer Macky
08:38 Metabolic controls and diabertic retinopathy. Jean-François Gauthier
08:55 A relation between obstructive sleep apnea and DME with nerve fiber layer infarcts. Stephen Sinclair
09:05 Role of leucocytes.Yuichiro Ogura
09:18 Correlation between DR and inflammation markers. Jean-François Gauthier
09:31 The interleukin-1 family in pathogenesis of PDR and traumatic vitreoretinopathy. Andriy Sergienko
09:38 The role of interleukin-6 in the pathogenesis of PDR. Sibel Kadayifcilar
09:45 Bilateral endogenous candida endophthalmitis following intravenous catheterization in diabetic patients. Mahmoud Soliman
09:55 Coffee Break
10:25 Update on angiogenesis. Yuichiro Ogura
10:40 Reducing of venous filling time between pre and post PRP correlated to the progression of retinal neovascularization. Yun-Sik Yang
10:48 Medical treatment of diabetic retinopathy. Anne Katrin Sjoeli
11:03 Role of the Vitreous in PDR. Jerry Sebag
11:23 Pathogenesis and staging of PDR. Peter Kroll
11:43 PVD status as one strategical parameter in PDR. Claude Boscher
11:50 One Hour Discussion moderated by Giampaolo Gini including ARVO Key Point and related posters (Ates Yanyali, Merih Soylu, Sema Oruç Dündar, Kuddusi Erkiliç, Nihal Demircan, Selim Kocabora)
 
12:50 Lunch Break
 
SCREENING AND IMAGING
14:10 Quantitative assessment of DME with Heidelberg retinal tomography. Selcen Celik
14:20 Agreement between quantitative analysis of fundus and angiographic images by photoshop software and clinical judgment. Ali R. Ramezani
14:28 Macular edema visualisation, detection and estimation in DR. Paola Salvetti
14:38 Graphic blur simulation of vision loss in patients with macular disease using results of discriminated target central fields. Stephen Sinclair
14:45 Does screening improve the results of treatment for diabetic retinopathy? Richard Newsom
14:55 Visual field changes in diabetic patients: frequency doubling perimetry versus standard automated perimetry. Mahmoud Soliman
15:03 Screening for diabetic retinopathy.The Scottish Experience. Mun Seng Lee
15:10 Discussion moderated by Frank Koch including ARVO Key Point and related posters (Alper Erdinç)
   
15:30 Relya Zivojnovic Award : John Scott lecture Picture Gallery    
  The vitreoretinal interface and posterior vitreous detachment in proliferative diabetic retinopathy
16:00 Coffee Break
   
PARALLEL SESSIONS
16:30 - 18:30 Young EVRS Club
16:30 - 18:00 The 12 last months news
Vail Meeting Review. Klaus Lucke
Bibliography Review. Frank Becquet & Jean-François Le Rouic
   
19:00 Cruise Dinner on the Bosphorus  
 
Tuesday, September 14th
 
DIABETIC MACULAR EDEMA
08:00 Current Opinion on management of DME - a research done by YEVRS. Mun Seng Lee
08:05 Retinal glial reaction patterns and their relationship to DME. Didier Ducournau
   
  Laser
08:16 DME -treatment with argon laser photocoagulation. Jiri Rehak
08:25 Subthreshold indirect green wavelength photocoagulation for primary treatment in severe DME. Claudine Guyot-Argenton
08:33 Infrared Micropulse Photocoagulation in DME. Paola Salvetti
08:43 Micropulsed diode laser therapy for diabetic macular oedema. Dominic McHugh
08:53 PDT for choroidal neovascularization in course of DR. Ariadna Gierek-Lapinska
09:00 Discussion moderated by Stephen Sinclair and Martine Mauget-Faysse including ARVO Key Point
   
  Triamcinolone
09:30 IVT application in diabetic eyes: rationale, indications and mode of action. Silvia Bopp
09:42 Panel discussion moderated by Silvia Bopp with all the authors (Imren Akkoyun, Cengiz Aras, Remzi Avci, Figen Batioglu, Mehmet Cakir, Mohammad Dehghan, Morteza Entezari, Berkant Kaderli, Murat Karacorlu, Mahmoud Soliman, Noha Khater, Sengül Özdek, Murat Sonmez, Yusuf Uysal, Eylem Yaman, Abdullah Özkiris, Hamdi Er, Faruk Eroglu, Selim Kocabora,Rubens Siqueira, Gungor Sobaci, Ibrahim Taskintuna, Yuksel Totan, Güngsel Yilmaz, MeldaYenerel)
10:15 Coffee Break
   
  Pars Plana Vitrectomy alone
10:45 Vitreoretinal surgery in DME. Siv Åström
10:54 Diabetic macular traction syndrome. Jiri Rehak
11:03 Vitrectomy for diffuse DME - a prospective randomized clinical trial. Ulrike Stolba
11:12 The proof of short-term PFCL efficacy in management of PDR with OCT. Victor Kazaikin
11:21 Triamcinolone assited vitrectomy for hyaloid visualization in DME. Fabio Patelli Film
   
  Internal Limiting Membrane Peeling
11:30 Trypan-blue assisted ILM removal in DME. Murat Oncel
11:39 DME "Profilactive" Surgery. Athanasios Nikolakopoulos
11:51 Visual outcome and OCT features of patients with DME after ILM peeling. Fabio Patelli
11:59 ILM removal for severe DME. Ferenc Kuhn
12:10 PPV and ILM removal in DME unresponsive to grid laser photocoagulation. Ates Yanyali
12:17 Vitrectomy with ILM peeling for DME. Ivan Fiser
12:26 Macular surgery in diabetic cases. Tugrul Altan Film
   
12:35 Lunch break
   
  ILM Peeling + Triamcinolone
13:45 ILM peeling and intravitreal triamcinolone acetonide for refractory diabetic CME. Francesco Boscia
13:53 Evaluating adjunctive surgical procedures of vitrectomy for DME with visual acuity and optical coherence tomographic outcomes. Frank Becquet
14:02 Vitrectomy with Intravitreal Steroid. Sundaran Natarajan Film
14:11 One Hour Discussion moderated by Ferenc Kuhn including ARVO Key Point and related posters (Ozdamar Yasemin,Yavuz Bardak, Yesim Ercalik, Ates Yanyali, Avinoam Ophir)
 
25 GAUGE SESSION
15:10 Transconjonctival Wide-Field 25 Gauge Vitrectomy. Frederic Hamon
15:25 25 G Vitrectomy - Our Initial Experience. Sundaran Natarajan
15:35 Does size really matter in PDR? Stephan Nikolic
15:43
15:52
16:01 Four port PPV using 25G system. Ziad Bashshur
16:06 Discussion moderated by Murat Karacorlu including ARVO Key Point and related posters (Ates Yanyali)
16:30 Coffee Break
   
PARALLEL SESSIONS
17:00-18:30 Angiogenesis Seminar
17:00-18:30 True To Live Surgery
 
19:30 Cocktail and Gala Dinner at the Ciragan Palace Picture Gallery  
 
Wednesday, September 15th
 
PROLIFERATIVE DIABETIC RETINOPATHY
Discussions moderated by Mahmoud Soliman and Khaled El-Rakhawy
08:00 Current Opinion on management of PDR - a research done by YEVRS. Mario Facino
  Laser
08:05 PDR - Treatment with argon laser. Jiri Rehak
08:14 Alpha - Lipoid acid therapy after panretinal laser coagulation in diabetic patients. Maria Sydorova
08:22 Kinetic anaesthesia for diabetic laser surgery. Richard Newsom
   
Technique
08:30 The prognosis of vitreoretinal surgery duration in diabetic patients. Pavel Rylov
08:37 The effect of preoperative scatter photocoagulation on visual outcome on vitrectomize diabetic cases. Yaprak Banu Ünver
08:44 Surgical management of complicated diabetic RD by simple PPV techniques. Khaled El-Rakhawy
08:55 Step-wise surgical approach in diabetic eyes complicated by traction RD. Ziya Kapran Film
09:02 Surgical techniques for PDR. Didier Ducournau Film
09:11 Vitreous surgery for PDR. Jerzy Nawrocki Film
09:19
09:27
09:36 The main outcomes of combined phaco, PCIOL and PPV in patients with PDR. Baris Yeniad
09:45 Discussion including ARVO Key Point and related posters (Alexandre Denoyer, Yuksel Sullu, Young-Joon Jo, Sundaran Natarajan)
10:10 Coffee Break
   
  Illuminating and Viewing Systems
10:30 Xenon-arc light assisted PPV in PDR. Lars-Olof Hattenbach
10:39 Ophthalmic microendoscope assisted diabetic vitrectomy. Emin Özmert
10:48 Recurrent Intravitreal haemorrhage after endoscopy assisted vitrectomy for severe PDR. Claude Boscher
10:57 Vitreous surgery without endoillumination for proliferative diabetic retinopathy. Jerzy Nawrocki Film
11:05
11:13 Why should true bimanual surgery be accepted as the gold standard for PDR. Frank Koch
11:22 Bimanual surgical techniques in retinal surgery. Athanasios Nikolakopoulos
11:33 Bimanual vitrectomy in diabetic traction retinal detachment. Nur Acar Film
11:40 PDR:triamcinolone assisted bimanual surgery and "re-flow" technique. Cesare Forlini Film
11:47 Discussion including ARVO Key Point and related posters (Ates Yanyali)
   
12:00 General Assembly
   
13:00 Lunch break
   
Tamponade
14:20 SF6 in diabetic tractional retinal detachment. Bernardete Pessoa
14:27 Surgical treatment of PDR with long term tamponade by silicon oil. Igor Serejine
14:35 Clinical experience with heavy silicone oil in diabetic tractional retinal detachment. Melda Yenerel
14:44 The patency of superior ciliary sulcus in aphakic silicon-filled eyes: an ultrasound biomicroscopy study. Tamer Macky
14:50 Vitrectomy with silicone oil tamponade in proliferative diabetic retinopathy. Marta Macedo
   
Clinical Series
15:00 Vitreoretinal surgery in severe PDR. Slobodanka Latinovic
15:07 Vitrectomy in diabetic retinopathy. Natalia Ferreira
15:15 Visual outcome after PPV for vitreous and/or subhyaloidal hemorrage in diabetic patients. Zerrin Bayraktar
15:22 Visual prognosis after PPV for diabetic TRD. Ziya Kapran
15:30 Vitreous surgery for proliferative diabetic retinopathy with end stage renal disease. Jerzy Nawrocki
   
Complications
15:40 Intraoperative and Postoperative Complications After Vitrectomy in Diabetic Cases. Nur Acar
15:47 Early post vitrectomy diabetic vitreous hemorrage: incidence and associated factors. Zerrin Bayraktar
15:54 Effect of tranexamic acid on early post vitrectomie diabetic hemorrhage. Ali Ramezani
16:00 The effect of PPV on rubeosis iridis and IOP, an analysis of associated factors. Tugrul Altan
16:05
16:15 One Discussion including ARVO Key Point and related posters (Yuksel Sullu, Ahmet Gucukoglu)
 
POSTERS
1) Outcomes of Triamcinolone assisted PPV for retinal diseases. Yasemin Ozdama
2) Comparison of effectiveness of modified grid laser photocoagulation with PPV and ILM removal in diffuse DME. Ates Yanyali
3) Surgical treatment for subfoveal hard exudates secondary to DME.Yesim Ercalik
4) Comparison of triamcinolone acetonide assisted posterior vitreous removal and ILM peeling in diabetic patients. Yavuz Bardak
5) Risk factors for vitreous hemorraghe in subjects with DR. Ates Yanyali
6) Comparison of serum nitric oxide, glutathione and plasma malondialehyde level with grade of retinopathy in patients with diabetes mellitus. Sema Oruç Dündar
7) Determination of vitreous Interleukin-1 and tumor necrosis factor levels in PDR. Nihal Demircan
8) The effect of atorvastatin on ocular blood flow velocities in patients with DR. Kuddusi Erkiliç
9) The role of oxidative stress and hepatocyte growth factor in DR. Merih Soylu
10) PPV and bimanual delamination of membranes in patients with severe diabetic fibrovascular proliferation. Ates Yanyali
11) 25-Gauge transconjunctival sutureless vitrectomy in diabetic patients. Ates Yanyali
12) Combined phaco and PPV in diabetic patients. Yuksel Sullu
13) Combined phaco and silicone oil removal with assistance of anterior chamber maintainer.Yuksel Sullu
14) Rubeosis iridis after PPV in PDR. Yuksel Sullu
15) The predictive value of echography in diabetic vitreous hemorrhage. Selim Kocabora
16) Surgical management of patients with complicated PDR : the French 'tourangelle' experience. Alexandre Denoyer
17) The results of combined PPV, phaco and IOL implantation in PDR. Young-Joon Jo
18) OCT assessment of DME: Comparison with fluorescein angiographic and clinical findings. Alper Erdinç
19) Safety of IVT for diffuse DME. Gungor Sobaci
20) IVT In persistant DME: Short-term Results. Selim Kocabora
21) IVT for diffuse DME. Ibrahim Taskintuna
22) The Effectiveness of IVT for DME. Faruk Eroglu
23) IVT for refractory diffuse DME. Yuksel Totan
24) IVT in treatment of pseudophakic macular edema in diabetic patients. Gürsel Yilmaz
25) IVT for diffuse DME. Hamdi Er
26) Pattern electroretinogram for monitoring the efficacy of IVT in DME. Abdullah Özkiris
27) IVT as primary treatment for DME. Abdullah Özkiris
28) Endophthalmitis following IVT in a diabetic patient. Melda Yenerel
29) OCT findings in DME after IVT. Eylem Yaman
30) The efficacy and safety of IVT for DME in eyes with and without laser photocoagulation. Yusuf Uysal
31) Short term results of IVT for the treatment of DME. Murat Sonmez
32) Posterior subtenon and IVT for DME. Sengül Özdek
33) IVT during phaco for patients with DME and dense cataracts. Noha Khater
34) IVT for DME: Part I: Refractory Cases: Two years experience. Tamer Macky
35) IVT for DME: Part II: Initial Intervention. Mahmoud M Soliman
36) Prediction of visual outcome after IVT for diffuse DME using Lotmar visometer. Berkant Kaderli
37) Posterior subtenon Triamcinolone injection for refractory DME; a randomized clinical trial. Morteza Entezari
38) IVT for refractory DME, a randomized clinical trial. Mohamad H. Dehghan
39) Early period OCT findings in DME after IVT. Mehmet Cakir
40) IVT for DME: an optical coherence tomography study. Figen Batioglu
41) IVT for chronic DME with severe foveal hard exudates. Remzi Avci
42) The effect of IVT on ontrast sensitivity in DME. Cengiz Aras
43) IVT and IOP. Imren Akkoyun
44) Duration of the effect of IVT as treatment of diffuse DME. Imren Akkoyun
45) In vitro evaluation of substained-release intravitreal dexamethasone implants. Rubens Siqueira
46) Transscleral diopsy for peripheral retinal ablation. Sundaran Natarajan
47) Influence of phacoemulsification surgery on progression of DR. Ahmet Gucukoglu

48) Diabetic vitreopapillary traction and macular edema. Avinoam Ophir



Public Informations ¦ Industrial news ¦ Meetings
Training school ¦ EVRS Members ¦ Statutes
Why EVRS ?
Contact
Home

© evrs 2001